The absence of elevated CA-125 in a collision ovarian tumor consisting of a combined tumor and mature teratoma likely results from the tumor’s composite nature—specifically, the contribution of the mature teratoma component, which does not produce CA-125, and potentially a limited or less active cystadenocarcinoma component. This evidence concerns the gene MUC16 and teratoma.